Value of virtual touch tissue imaging quantification (VTIQ) in the differential diagnosis of TI-RADS 4 (a-b) thyroid nodules on ultrasound
Shu WU,Hui-xiong XU,Jun-mei XU,Xiao-wan BO,Xiao-long LI,Bo-ji LIU,Dan-dan LI,Lin FANG,Shen QU
DOI: https://doi.org/10.3969/j.issn.1005-8001.2015.05.004
2015-01-01
Abstract:Objective To assess the value of virtual touch tissue imaging quantification (VTIQ) in differentiating benign and malignant TI-RADS 4 (a-b) thyroid nodules on ultrasound. Methods The ultrasound and VTIQ features of 115 TI-RADS 4 (a-b) thyroid nodules confirmed by pathology or fine needle aspiration cytology (FNAC) in 115 patients were reviewed. Sonographic features including echogenicity, blood flow, microcalcification, margin, and antiparallel shape of the nodules, were analyzed. The VTIQ was expressed as the shear wave velocity (SWV) with greater SWV representing stiffer tissue. Receiver operating characteristic (ROC) curve was analyzed and the best cutoff value was obtained using pathology finding as gold standard. The sensitivity, specificity, accuracy, positive predictive value and negative predictive value for differential diagnosis were calculated. Results The 115 FNAC and pathologically proven TI-RADS 4 (a-b) thyroid nodules included 61 benign and 54 malignant nodules. More than or equal to two malignant features of ultrasound TI-RADS were regarded as malignant nodule..The sensitivity,.specificity, accuracy,.positive predictive value and negative predictive value of ultrasound TI-RADS for differential diagnosis were 79.6%(43/54), 50.8%(31/61), 64.3%(74/115), 58.9%(43/73), 73.8%(31/42), respectively. The areas under the ROC curve (AUC) of TI-RADS, VTIQ and combining diagnosis of thyroid cancer were 0.652, 0.694 and 0.692, respectively. There were no statistical differences between the three methods in terms of AUC (all P>0.05);.The best cutoff value of VTIQ is 2.77 m/s and its corresponding sensitivity, specificity, positive, accuracy, predictive value and negative predictive value of VTIQ were 66.7%(36/54), 72.1%(44/61), 69.5%(80/115), 67.9(36/53), 71.0%(44/62), respectively. For the combined technology, the values were 48.1%(26/54), 90.2%(55/61), 70.4%(81/115), 81%(26/32), 66.3%(55/83), respectively. Conclusion Combined technology of TI-RADS and VTIQ showed superior specificity in the differential diagnosis between malignant and benign TI-RADS 4 (a-b) nodules compared with ultrasound TI-RADS or VTIQ alone. VTIQ should be used as a supplementary technology for ultrasound.